TH and metastatic neoplasm: This protocol led to an increase in sensitivity of TH mRNA detection by RT-qPCR from 58% to 90% [201] and has since been implemented by the same group for MRD detection in patients with metastatic disease enrolled on the international phase 3 HR-NBL-1/SIOPEN trial [187,207].